knowledge -WSS

knowledge

author：leisure time 2025-10-01 13:12:50 Page View：27785

close-up of psoriasis on a hand. -- biotech coverage from STAT — A close-up of psoriasis on a hand. Adobe

San Francisco startup Alumis Inc. has raised $259 million in a bid to best big pharma’s work in plaque psoriasis.

Alumis announced its Series C round Wednesday and plans to move its lead drug into Phase 3 trials. Venture firm Foresite Capital, which incubated Alumis, co-led the financing with Samsara BioCapital and venBio Partners.

Alumis’ lead drug, ESK-001, is an oral medicine designed to help patients with the most common type of psoriasis by inhibiting a signaling protein called TYK2. Research has shown that the TYK2 protein plays a role in diseases where the immune system overreacts, which has made it a popular drug target in recent years.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At ASCO, AstraZeneca reports strong data for breast cancer drug
Next article： ChatGPT in medicine: STAT answers readers' burning questions

knowledge

Medical leaders decry Supreme Court decision on affirmative action

STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

Hospitals use virtual reality to design more inclusive rooms for kids

ResearcherHaripriyaSathyanarayananobservingasapediatricparticipantexploresahospitalroominvirtualreal

How one medical school became remarkably diverse

ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

See how much Covid

NewYork-PresbyterianHospitalreceived$631millionfromtheCovid-19ProviderReliefFund.CindyOrd/GettyImage